Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06348394 · ClinicalTrials.gov registry record · NA
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion
A NA study of Left Atrial Appendage Closure, sponsored by Baylor Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 444
- Enrollment target
- 1
- Study location
NCT06348394: Recruiting NA study of Left Atrial Appendage Closure, sponsored by Baylor Research Institute.
NCT06348394 is a NA study of Left Atrial Appendage Closure that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 444 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06348394, a NA study of Left Atrial Appendage Closure, is actively recruiting participants, sponsored by Baylor Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 444 participants
- Enrollment target
- 1
- Study location
Study Summary
This single-center, prospective, randomized study will evaluate the safety and feasibility of Intracardiac echocardiography (ICE)-guided Left atrial appendage closure (LAAC) when compared to the traditional Transesophageal echocardiography (TEE) approach.
Primary Outcome
Procedural success specifies that the device should be implanted in the correct position measured as: Peri-device leaks greater than 5 milliliters on color doppler (Yes/No)
Conditions Studied
Interventions
- OTHER Intracardiac Echocardiography
Study Locations (1)
Texas
- Baylor Scott and White Heart Hospital - Plano
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 444 participants |
| Start Date | 2025-02-25 |
| Est. Completion | 2026-12-30 |
| Phase | NA |
What NCT06348394 shows while recruiting
NCT06348394 is an interventional study that assigns participants to a tested intervention. The registered 444 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Left Atrial Appendage Closure appearing as the primary indexed condition, and to 1 intervention - of which Intracardiac Echocardiography is the first listed.
NCT06348394 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06348394 about?
NCT06348394 is a clinical study titled "Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion". This single-center, prospective, randomized study will evaluate the safety and feasibility of Intracardiac echocardiography (ICE)-guided Left atrial appendage closure (LAAC) when compared to the traditional Transesophageal echocardiography (TEE) approach.
What is the current status of trial NCT06348394?
This trial is currently recruiting. It is a NA study. The enrollment target is 444 participants. The study started on 2025-02-25. Estimated completion is 2026-12-30.
What conditions does trial NCT06348394 study?
This clinical trial studies the following conditions: Left Atrial Appendage Closure.
What interventions are being tested in trial NCT06348394?
The interventions under investigation include: Intracardiac Echocardiography (OTHER).
Who is sponsoring clinical trial NCT06348394?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06348394 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Left Atrial Appendage Closure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06348394's enrollment target sits among peer trials
444 233rd of 2000 higher than 1,768 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06700343 · 444 participants · Phase 3
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
- NCT01280994 · 445 participants · Phase 2
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
- NCT03504800 · 445 participants
OCT in Diagnosis of Irregular Corneas
- NCT04751435 · 445 participants · NA
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI